Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
Top Cited Papers
- 11 August 2006
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 44 (2) , 99-106
- https://doi.org/10.1136/jmg.2006.043802
Abstract
The major factors individually reported to be associated with an increased frequency of CDKN2A mutations are increased number of patients with melanoma in a family, early age at melanoma diagnosis, and family members with multiple primary melanomas (MPM) or pancreatic cancer. These four features were examined in 385 families with > or =3 patients with melanoma pooled by 17 GenoMEL groups, and these attributes were compared across continents. Overall, 39% of families had CDKN2A mutations ranging from 20% (32/162) in Australia to 45% (29/65) in North America to 57% (89/157) in Europe. All four features in each group, except pancreatic cancer in Australia (p = 0.38), individually showed significant associations with CDKN2A mutations, but the effects varied widely across continents. Multivariate examination also showed different predictors of mutation risk across continents. In Australian families, > or =2 patients with MPM, median age at melanoma diagnosis < or =40 years and > or =6 patients with melanoma in a family jointly predicted the mutation risk. In European families, all four factors concurrently predicted the risk, but with less stringent criteria than in Australia. In North American families, only > or =1 patient with MPM and age at diagnosis < or =40 years simultaneously predicted the mutation risk. The variation in CDKN2A mutations for the four features across continents is consistent with the lower melanoma incidence rates in Europe and higher rates of sporadic melanoma in Australia. The lack of a pancreatic cancer-CDKN2A mutation relationship in Australia probably reflects the divergent spectrum of mutations in families from Australia versus those from North America and Europe. GenoMEL is exploring candidate host, genetic and/or environmental risk factors to better understand the variation observed.Keywords
This publication has 44 references indexed in Scilit:
- Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).2000
- High Frequency of Multiple Melanomas and Breast and Pancreas Carcinomas in CDKN2A Mutation-Positive Melanoma FamiliesJNCI Journal of the National Cancer Institute, 2000
- Genotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 MutationsJNCI Journal of the National Cancer Institute, 2000
- Genotype/Phenotype and Penetrance Studies in Melanoma Families with Germline CDKN2A MutationsJournal of Investigative Dermatology, 2000
- Characterization of ligurian melanoma families and risk of occurrence of other neoplasiaInternational Journal of Cancer, 1999
- Counseling and DNA Testing for Individuals Perceived to Be Genetically Predisposed to Melanoma: A Consensus Statement of the Melanoma Genetics ConsortiumJournal of Clinical Oncology, 1999
- CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas.1999
- CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.1999
- Mutation testing in melanoma families: INK4A, CDK4 and INK4DBritish Journal of Cancer, 1999
- Melanoma development in relation to nonfunctional p16/INK4A protein and dysplastic naevus syndrome in Swedish melanoma kindredsMelanoma Research, 1999